Back to Search Start Over

Tolerability & long-term disease control by IGHV mutation status among CLL patients on ibrutinib arm of E1912.

Authors :
Shanafelt TD
Wang XV
Hanson CA
Paietta E
O'Brien SM M.D
Barrientos JC
Jelinek DF
Braggio E
Leis JF
Zhang C
Barr PM
Cashen AF
Mato AR
Singh AK
Mullane M
Little RF
Erba HP
Stone RM
Litzow MR
Tallman MS
Kay NE
Source :
Blood advances [Blood Adv] 2024 Aug 20. Date of Electronic Publication: 2024 Aug 20.
Publication Year :
2024
Publisher :
Ahead of Print

Details

Language :
English
ISSN :
2473-9537
Database :
MEDLINE
Journal :
Blood advances
Publication Type :
Academic Journal
Accession number :
39163612
Full Text :
https://doi.org/10.1182/bloodadvances.2024013474